| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), SNDX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.8K | $11.75M | - | |
| Dir | 239.8K | - | - | |
| CFO | 139.3K | $2.64M | - | |
| Dir | 124.0K | - | - | |
| Dir | 114.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | Metzger Michael A52 | Chief Executive Officer | Sell | 7,534 | $9.29 | $69,953.19 | -2.5% | +65.5% | +145.5% | |
| Jul 16, 2025 | Goldan Keith A.49 | Chief Financial Officer | Sell | 1,296 | $9.29 | $12,033.36 | -1.4% | +65.5% | +145.5% | |
| May 19, 2025 | Goldan Keith A.49 | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +3.3% | +70.6% | +108.2% | |
| May 19, 2025 | Katkin Keith65 | Director | Buy | 10,000 | $9.11 | $91,120.00 | +11.1% | +70.6% | +108.2% | |
| May 19, 2025 | Huber Martin H. Jr. | Director | Buy | 5,000 | $8.99 | $44,950.00 | +6.8% | +70.6% | +108.2% | |
| May 16, 2025 | Botwood Nicholas A.J. | Head Of R&D, CMO | Buy | 11,765 | $9.00 | $105,826.17 | +50.3% | +62.8% | +123.5% | |
| Mar 4, 2025 | Metzger Michael A52 | Chief Executive Officer | Sale+OE | 7,814 | $15.05 | $117,563.97 | -2.5% | -23.6% | +50.3% | |
| Feb 10, 2025 | Goldan Keith A.49 | Chief Financial Officer | Sell | 3,777 | $15.50 | $58,558.61 | -4.0% | -27.4% | +40.9% | |
| Feb 10, 2025 | Metzger Michael A52 | Chief Executive Officer | Sell | 13,288 | $15.50 | $206,017.15 | -4.2% | -27.4% | +40.9% | |
| Feb 10, 2025 | Gallagher Neil | President, Head Of R&D | Sell | 4,618 | $15.50 | $71,597.47 | -5.1% | -27.4% | +40.9% |